Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: David Bikard

Eligo Bioscience – eligobiotics

Posted on by

Eligo Bioscience is a biotech company developing a new generation of antibiotics, called “eligobiotics”.

Eligo Bioscience – eligobiotics

Eligo Bioscience Continue reading →

Posted in Biotech Companies, Biotech Companies France | Tagged antibiotic, antibiotics, bacteria, bacterial ecosystem, biodefense, David Bikard, Eligo, Eligo Bioscience, Eligo Bioscience - eligobiotics, eligo biotics, EligoBioscience, eligobiotic, eligobiotics, Laure Saujet, Luciano Marraffini, Matthieu Galtier, nanodelivery, nanodelivery vector, nanodelivery vectors, nuclease, protein-based nanodelivery vectors, RNA-guided nuclease, Staphylococcus, Staphylococcus aureus, Timothy Lu, virulent bacterial pathogen, Xavier Duportet

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress